Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals (NQ: REGN)
333.34 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:57 PM EDT, Apr 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 332.15 (4)
Ask (Size) 333.50 (1)
Prev. Close 333.34
Today's Range 333.34 - 333.34
52wk Range 281.89 - 442.00
Shares Outstanding 105,949,824
Dividend Yield N/A
Performance
YTD
-10.50%
-10.50%
1 Month
-18.10%
-18.10%
3 Month
-20.14%
-20.14%
6 Month
-15.66%
-15.66%
1 Year
+3.72%
+3.72%
Top News
More News
Regeneron to Report First Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on May 7, 2019
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2019 financial and operating results on Tuesday, May 7, 2019, before the U.S. financial markets... Read More
from PR Newswire
Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases
from PR Newswire
More News
Read More
Alnylam and Regeneron Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases
from Business Wire News Releases
Analysts Forecast 10% Gains Ahead For PWB
category ETFs
from ETF Channel
Health-care drama has now spread to biopharma stocks
category XLV , JNJ , Pharmaceuticals , and 18 more.
from MarketWatch
Notable Monday Option Activity: REGN, XEC, IFF
category Stocks
from Market News Video
Regeneron Pharmaceuticals Becomes #200 Most Shorted S&P 500 Component, Replacing Roper Technologies
category Stocks
from Market News Video
5 things to know about Hookipa Pharma ahead of its IPO
category MRNA , Company Announcements , VBIV , and 13 more.
from MarketWatch
Is Alnylam Pharmaceuticals a Buy Now?
category MDCO , SNY , REGN , and 2 more.
from Motley Fool
Regeneron, Alnylam Strike $1B Collaboration For RNAi-based Therapeutics
category Trading Ideas , Biotech , REGN , and 5 more.
from Benzinga
Stocks Showing Improved Relative Strength: Regeneron Pharmaceutical
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More

© Copyright FinancialContent Services, Inc.
Terms and Conditions Privacy Policy Contact Us twitter linkedin twitter

Contact Us

(888) 688-9880

Services

Financial Widgets Financial Pages Web Services Consulting Financial Calculations Stock Data for Excel Newspaper Services For Advertisers Monetization Services Content Syndication Press Release Syndication

Services by Industry

Online Media Financial Services Newspaper Investor Relations Financial Blog Corporate Intranets Digital Signage Television Android Developers iOS Developers Wire Services Radio

About Us

Overview Careers Management Team Latest News Newsletters

Support

Support Articles Report an issue